On September 11th, 2023, the U.S. Food and Drug Administration approved and authorized the emergency use of an updated COVID-19 vaccine formulated to closely target circulating variants and to provide better protection against serious consequences of COVID-19.
Per the FDA’s website, here is a summary of recommended vaccination schedules based on your age group and previous vaccination status:
- Individuals 5 years of age and older regardless of previous vaccination are eligible to receive a single dose of an updated mRNA COVID-19 vaccine at least 2 months since the last dose of any COVID-19 vaccine.
- Individuals 6 months through 4 years of age who have previously been vaccinated against COVID-19 are eligible to receive one or two doses of an updated mRNA COVID-19 vaccine (timing and number of doses to administer depends on the previous COVID-19 vaccine received).
- Unvaccinated individuals 6 months through 4 years of age are eligible to receive three doses of the updated authorized Pfizer-BioNTech COVID-19 Vaccine or two doses of the updated authorized Moderna COVID-19 Vaccine.
For more information regarding COVID-19 and the updated vaccine, please visit the below resources:
- https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html
- https://www.fda.gov/news-events/press-announcements/fda-takes-action-updated-mrna-covid-19-vaccines-better-protect-against-currently-circulating
To read previous COVID-19 Maxor updates, click here.
